These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22932447)

  • 1. The evaluation of AZ66, an optimized sigma receptor antagonist, against methamphetamine-induced dopaminergic neurotoxicity and memory impairment in mice.
    Seminerio MJ; Hansen R; Kaushal N; Zhang HT; McCurdy CR; Matsumoto RR
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):1033-44. PubMed ID: 22932447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. σ Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation.
    Robson MJ; Seminerio MJ; McCurdy CR; Coop A; Matsumoto RR
    Pharmacol Rep; 2013; 65(2):343-9. PubMed ID: 23744418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo.
    Kaushal N; Seminerio MJ; Robson MJ; McCurdy CR; Matsumoto RR
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):960-71. PubMed ID: 22921523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice.
    Kaushal N; Seminerio MJ; Shaikh J; Medina MA; Mesangeau C; Wilson LL; McCurdy CR; Matsumoto RR
    Neuropharmacology; 2011; 61(5-6):992-1000. PubMed ID: 21762711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studies.
    Matsumoto RR; Shaikh J; Wilson LL; Vedam S; Coop A
    Eur Neuropsychopharmacol; 2008 Dec; 18(12):871-81. PubMed ID: 18755577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine.
    Seminerio MJ; Robson MJ; Abdelazeem AH; Mesangeau C; Jamalapuram S; Avery BA; McCurdy CR; Matsumoto RR
    AAPS J; 2012 Mar; 14(1):43-51. PubMed ID: 22183188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity.
    Belcher AM; O'Dell SJ; Marshall JF
    Neuropsychopharmacology; 2005 Nov; 30(11):2026-34. PubMed ID: 15900317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus.
    Seminerio MJ; Robson MJ; McCurdy CR; Matsumoto RR
    Eur J Pharmacol; 2012 Sep; 691(1-3):103-9. PubMed ID: 22820108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
    Achat-Mendes C; Anderson KL; Itzhak Y
    Neuropsychopharmacology; 2007 Mar; 32(3):531-41. PubMed ID: 16760923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice.
    Seminerio MJ; Kaushal N; Shaikh J; Huber JD; Coop A; Matsumoto RR
    Pharmacol Biochem Behav; 2011 Mar; 98(1):12-20. PubMed ID: 21130800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
    Itzhak Y; Gandia C; Huang PL; Ali SF
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine.
    Ke JJ; Chen HI; Jen CJ; Kuo YM; Cherng CG; Tsai YP; Ho MC; Tsai CW; Yu L
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):239-47. PubMed ID: 18076959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.
    Bourque M; Liu B; Dluzen DE; Di Paolo T
    Biochem Pharmacol; 2007 Nov; 74(9):1413-23. PubMed ID: 17825264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization.
    Itzhak Y; Martin JL; Black MD; Ali SF
    Neuropharmacology; 1998 Jun; 37(6):781-91. PubMed ID: 9707292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
    Terleckyj I; Sonsalla PK
    J Pharmacol Exp Ther; 1994 Apr; 269(1):44-50. PubMed ID: 7513362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers associated with testosterone enhancement of methamphetamine-induced striatal dopaminergic neurotoxicity.
    Buletko AB; Dluzen DE; McDermott JL; Darvesh AS; Geldenhuys WJ
    Neurotoxicol Teratol; 2012; 34(3):338-43. PubMed ID: 22521941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity.
    Yuan J; Callahan BT; McCann UD; Ricaurte GA
    J Neurochem; 2001 Jun; 77(5):1338-47. PubMed ID: 11389185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the role of dopamine in the differential neurotoxicity patterns of methamphetamine, mephedrone, methcathinone and 4-methylmethamphetamine.
    Anneken JH; Angoa-Perez M; Sati GC; Crich D; Kuhn DM
    Neuropharmacology; 2018 May; 134(Pt A):46-56. PubMed ID: 28851615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation.
    Robson MJ; Turner RC; Naser ZJ; McCurdy CR; O'Callaghan JP; Huber JD; Matsumoto RR
    Exp Neurol; 2014 Apr; 254():180-9. PubMed ID: 24508558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.